Efficacy of Paroxetine (7.5 mg) in the treatment of menopause-associated vasomotor symptoms

被引：0
|
作者：
Belardo, Maria A. [1 ]
机构：
[1] Italian Hosp, Climacter Sect, Buenos Aires, DF, Argentina
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2019年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-4
引用
收藏
页码：1459 / 1459
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms
    Bonga, Krishna Nikhila
    Mishra, Archana
    Maiti, Rituparna
    Padhy, Biswa Mohan
    Meher, Bikash Ranjan
    Srinivasan, Anand
    [J]. OBSTETRICS AND GYNECOLOGY, 2024, 143 (03): : 393 - 402
  • [2] Paroxetine 7.5 mg Provided a Rapid and Durable Reduction in Vasomotor Symptoms Associated With Menopause Following Treatment Initiation
    Portman, David
    Pinkerton, JoAnn V.
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1333 - 1333
  • [3] Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
    Pinkerton, JoAnn V.
    Joffe, Hadine
    Kazempour, Kazem
    Mekonnen, Hana
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (01): : 50 - 58
  • [4] NONPHARMACOLOGIC TREATMENTS FOR MENOPAUSE-ASSOCIATED VASOMOTOR SYMPTOMS
    Goldstein, Karen M.
    Coeytaux, Remy
    Shepherd-Banigan, Megan
    Goode, Adam
    McDuffie, Jennifer
    Befus, Deanna
    Adam, Soheir
    Masilamani, Varsha
    Van Noord, Megan
    Williams, John
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S254 - S255
  • [5] Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms
    Umland, Elena M.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (03): : S14 - S19
  • [6] Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause
    Portman, David J.
    Kaunitz, Andrew M.
    Kazempour, Kazem
    Mekonnen, Hana
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (10): : 1082 - 1090
  • [7] Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society
    Santoro, NF
    Clarkson, TB
    Freedman, RR
    Fugh-Berman, AJ
    Loprinzi, CL
    Reame, NK
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01): : 11 - 33
  • [8] The relationship between vasomotor symptoms and menopause-associated dizziness
    Owada, Satoko
    Suzuki, Mitsuya
    [J]. ACTA OTO-LARYNGOLOGICA, 2014, 134 (02) : 146 - 150
  • [9] Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions
    Pachman, Deirdre R.
    Jones, Jason M.
    Loprinzi, Charles L.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2010, 2 : 123 - 135
  • [10] Pregabalin use for the management of menopause-associated vasomotor symptoms, a new alternative?
    Belardo, Maria A.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (12): : 1459 - 1460
12345